| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Adipocytokine signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 2 | Aldosterone-regulated sodium reabsorption 4 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] NR3C2 |
D00443 |
Spironolactone |
[6] 58, 67, 86, 113, 218, 225 |
| [3] SCNN1A, SCNN1B, SCNN1G |
D00649 |
Amiloride |
[3] 13, 225, 299 |
| D07447 |
| 3 | AMPK signaling pathway 3 genes, 2 drugs (DrugBank), 28 diseases shown |
[1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 4 | Apelin signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 5 | Arachidonic acid metabolism 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] PTGS1, PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 6 | Autophagy - animal 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 7 | Bile secretion 2 genes, 2 drugs (DrugBank), 21 diseases shown |
[1] CA2 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| [1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 8 | C-type lectin receptor signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 9 | cGMP-PKG signaling pathway 4 genes, 2 drugs (DrugBank), 18 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| 10 | Chemical carcinogenesis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 11 | Circadian entrainment 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 12 | Circadian rhythm 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 13 | Collecting duct acid secretion 3 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| [1] CA2 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| 14 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] F8 |
D00291 |
Desmopressin |
[6] 6, 64, 72, 75, 225, 288 |
| D02235 |
| 15 | Fluid shear stress and atherosclerosis 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 16 | FoxO signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 17 | Gap junction 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 18 | Gastric acid secretion 3 genes, 2 drugs (DrugBank), 19 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| [1] CA2 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| 19 | Glucagon signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 20 | Human cytomegalovirus infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 21 | Human papillomavirus infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 22 | Hypertrophic cardiomyopathy (HCM) 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 23 | IL-17 signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 24 | Insulin resistance 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 25 | Insulin signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 26 | Kaposi sarcoma-associated herpesvirus infection 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 27 | Leishmaniasis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 28 | Long-term depression 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 29 | Longevity regulating pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 30 | Longevity regulating pathway - multiple species 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 31 | Metabolic pathways 22 genes, 6 drugs (DrugBank), 37 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| [13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| [1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| [2] PTGS1, PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 32 | MicroRNAs in cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 33 | mTOR signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 34 | Neuroactive ligand-receptor interaction 1 gene, 2 drugs (DrugBank), 7 diseases shown |
[1] AVPR2 |
D00291 |
Desmopressin |
[6] 6, 64, 72, 75, 225, 288 |
| D02235 |
| D01213 |
Tolvaptan |
[3] 67, 72, 225 |
| 35 | NF-kappa B signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 36 | Nitrogen metabolism 13 genes, 1 drug (DrugBank), 6 diseases shown |
[13] CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| 37 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 38 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 39 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank), 15 diseases shown |
[2] ATP4A, ATP4B |
D00455 |
Omeprazole |
[15] 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 40 | Oxytocin signaling pathway 6 genes, 3 drugs (DrugBank), 21 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| [1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 41 | Pancreatic secretion 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] CA2 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| 42 | Pathways in cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 43 | Phospholipase D signaling pathway 1 gene, 2 drugs (DrugBank), 7 diseases shown |
[1] AVPR2 |
D00291 |
Desmopressin |
[6] 6, 64, 72, 75, 225, 288 |
| D02235 |
| D01213 |
Tolvaptan |
[3] 67, 72, 225 |
| 44 | PI3K-Akt signaling pathway 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 45 | Platelet activation 4 genes, 2 drugs (DrugBank), 7 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] PTGS1 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 46 | Proximal tubule bicarbonate reclamation 2 genes, 1 drug (DrugBank), 6 diseases shown |
[2] CA2, CA4 |
D00218 |
Acetazolamide |
[6] 13, 90, 115, 155, 225, 230 |
| D01196 |
| 47 | Purine metabolism 4 genes, 2 drugs (DrugBank), 18 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] PDE5A |
D02229 |
Sildenafil |
[16] 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| 48 | Regulation of lipolysis in adipocytes 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] PTGS1, PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 49 | Renin secretion 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 50 | Retrograde endocannabinoid signaling 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 51 | Salivary secretion 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 52 | Serotonergic synapse 2 genes, 1 drug (DrugBank), 2 diseases shown |
[2] PTGS1, PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 53 | Small cell lung cancer 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 54 | Taste transduction 3 genes, 1 drug (DrugBank), 3 diseases shown |
[3] SCNN1A, SCNN1B, SCNN1G |
D00649 |
Amiloride |
[3] 13, 225, 299 |
| D07447 |
| 55 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 56 | Thermogenesis 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 57 | Tight junction 2 genes, 1 drug (DrugBank), 17 diseases shown |
[2] PRKAA1, PRKAA2 |
D00944 |
Metformin |
[17] 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
| D04966 |
| 58 | TNF signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |
| 59 | Vascular smooth muscle contraction 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 60 | Vasopressin-regulated water reabsorption 1 gene, 2 drugs (DrugBank), 7 diseases shown |
[1] AVPR2 |
D00291 |
Desmopressin |
[6] 6, 64, 72, 75, 225, 288 |
| D02235 |
| D01213 |
Tolvaptan |
[3] 67, 72, 225 |
| 61 | VEGF signaling pathway 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] PTGS2 |
D00141 |
Indometacin |
[2] 225, 271 |
| D01565 |
| D02110 |